Literature DB >> 10225914

Structural requirements of the major protective antibody to Haemophilus influenzae type b.

L Hougs1, L Juul, A Svejgaard, T Barington.   

Abstract

Protective antibodies to the important childhood pathogen Haemophilus influenzae type b (Hib) are directed against the capsular polysaccharide (HibCP). Most of the antibody is encoded by a well-defined set of ("canonical") immunoglobulin genes, including the Vkappa A2 gene, and expresses an idiotypic marker (HibId-1). In comparison to noncanonical antibodies, the canonical antibody is generally of higher avidity, shows higher levels of in vitro bactericidal activity, and is more protective in infant rats. Using site-directed mutagenesis, we here characterize canonical HibCP antibodies expressed as antigen-binding fragments (Fabs) in Escherichia coli, define amino acids involved in antigen binding and idiotype expression, and propose a three-dimensional structure for the variable domains. We found that canonical Fabs, unlike a noncanonical Fab, bound effectively to HibCP in the absence of somatic mutations. Nevertheless, pronounced mutation-based affinity maturation was demonstrated in vivo. An almost perfect correlation was found between unmutated gene segments that mediated binding in vitro and those encoding canonical HibCP antibodies in vivo. Thus, the Vkappa A2a gene could be replaced by the A2c gene but not by the highly homologous sister gene, A18b, corresponding to the demonstrated usage of A2c but not of A18b in vivo. Similarly, only Jkappa1 and Jkappa3, which predominate in the response in vivo, were able to facilitate binding in vitro. These findings suggest that the restricted immunoglobulin gene usage in HibCP antibodies reflects strict structural demands ensuring relatively high affinity prior to somatic mutations-requirements met by only a limited spectrum of immunoglobulin gene combinations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225914      PMCID: PMC115997     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Model-building study of the combining sites of two antibodies to alpha (1----6)dextran.

Authors:  E A Padlan; E A Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 2.  Mutation drift and repertoire shift in the maturation of the immune response.

Authors:  C Berek; C Milstein
Journal:  Immunol Rev       Date:  1987-04       Impact factor: 12.988

3.  Extensive allelic sequence variation in the J region of the human immunoglobulin heavy chain gene locus.

Authors:  P S Mattila; J Schugk; H Wu; O Mäkelä
Journal:  Eur J Immunol       Date:  1995-09       Impact factor: 5.532

4.  Phage-display libraries of murine and human antibody Fab fragments.

Authors:  J Engberg; P S Andersen; L K Nielsen; M Dziegiel; L K Johansen; B Albrechtsen
Journal:  Methods Mol Biol       Date:  1995

5.  Capsular polymer of Haemophilus influenzae, type b. I. Structural characterization of the capsular polymer of strain Eagan.

Authors:  R M Crisel; R S Baker; D E Dorman
Journal:  J Biol Chem       Date:  1975-07-10       Impact factor: 5.157

6.  Somatic mutation and the maturation of immune response to 2-phenyl oxazolone.

Authors:  G M Griffiths; C Berek; M Kaartinen; C Milstein
Journal:  Nature       Date:  1984 Nov 15-21       Impact factor: 49.962

7.  Genetics of the phosphocholine-specific antibody response to Streptococcus pneumoniae. Germ-line but not mutated T15 antibodies are dominantly selected.

Authors:  J L Claflin; J Berry
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Cross-reactivity with Escherichia coli K100 in the human serum anticapsular antibody response to Haemophilus influenzae type B.

Authors:  R A Insel; P W Anderson
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

10.  Clonal recruitment and somatic mutation in the generation of immunological memory to the hapten NP.

Authors:  A Cumano; K Rajewsky
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  6 in total

1.  Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.

Authors:  Remy Robert; Marie-Paule Lefranc; Anahit Ghochikyan; Michael G Agadjanyan; David H Cribbs; William E Van Nostrand; Kim L Wark; Olan Dolezal
Journal:  Mol Immunol       Date:  2010 Nov-Dec       Impact factor: 4.407

Review 2.  Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations.

Authors:  E E Adderson
Journal:  Springer Semin Immunopathol       Date:  2001-12

3.  Prediction of the interacting surfaces in a trimolecular complex formed between the major dust mite allergen Der p 1, a mouse monoclonal anti-Der p 1 antibody, and its anti-idiotype.

Authors:  P B Furtado; R Furmonaviciene; J McElveen; H F Sewell; F Shakib
Journal:  Mol Pathol       Date:  2000-12

4.  Correlation of molecular characteristics, isotype, and in vitro functional activity of human antipneumococcal monoclonal antibodies.

Authors:  H E Baxendale; D Goldblatt
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

5.  Human recombinant antibodies against Plasmodium falciparum merozoite surface protein 3 cloned from peripheral blood leukocytes of individuals with immunity to malaria demonstrate antiparasitic properties.

Authors:  Rasmus Lundquist; Leif Kofoed Nielsen; Ali Jafarshad; Daw Soesoe; Lars Harder Christensen; Pierre Druilhe; Morten Hanefeld Dziegiel
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

6.  Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire.

Authors:  Yik Andy Yeung; Davide Foletti; Xiaodi Deng; Yasmina Abdiche; Pavel Strop; Jacob Glanville; Steven Pitts; Kevin Lindquist; Purnima D Sundar; Marina Sirota; Adela Hasa-Moreno; Amber Pham; Jody Melton Witt; Irene Ni; Jaume Pons; David Shelton; Arvind Rajpal; Javier Chaparro-Riggers
Journal:  Nat Commun       Date:  2016-11-18       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.